Modèles de données sélectionnés

Vous devez être connecté pour sélectionner plusieurs modèles de données, les télécharger ou les analyser.

3 Résultats de recherche.
Pertinence Commentaire Plus récent Moins récent

EUROASPIRE III- Coronary heart disease HRI Interview Questionnaire - HRI Interview Questionnaire

- 17/09/2021 - 1 Formulaire, 12 Groupes Item, 272 Eléments de données, 1 Langue
Groupes Item: Demographic Information, Smoking, Diet/Body weight, Physical activity, Blood pressure,Cholesterol and Diabetes, Risk factor awareness and targets, Lifestyle changes, Risk perception, Medication, Family history of cardiovascular disease, Physical measurements, Blood sample
Provided by Prof. Keil Source: Kotseva K, Wood D, De Backer G, De Bacquer D, Pyörälä K, Keil U; EUROASPIRE Study Group. Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries. Lancet. 2009 Mar 14;373(9667):929-40. doi: 10.1016/S0140-6736(09)60330-5. PubMed PMID: 19286092

EUROASPIRE III- Coronary heart disease HRI Record Questionnaire - HRI Record Questionnaire

- 17/09/2021 - 1 Formulaire, 3 Groupes Item, 133 Eléments de données, 1 Langue
Groupes Item: Inclusion criteria, Personal information, HRI Record Questionnaire
Provided by Prof. Keil Source: Kotseva K, Wood D, De Backer G, De Bacquer D, Pyörälä K, Keil U; EUROASPIRE Study Group. Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries. Lancet. 2009 Mar 14;373(9667):929-40. doi: 10.1016/S0140-6736(09)60330-5. PubMed PMID: 19286092

Lifestyle Questionnaire GSK study Chronic Coronary Heart Disease NCT00799903

- 20/09/2021 - 1 Formulaire, 11 Groupes Item, 73 Eléments de données, 1 Langue
Groupes Item: Diet, Alcoholic drinks, Weekly activity, Physical activity, Health-related limitations in physical activity, Symptoms limiting physical activity, Sleep, Stress assessment, Lifestyle comparison before and after heart problem, Lifestyle since first heart problem, Socio-economic
Study ID: 100601 Clinical Study ID: LPL100601 Study Title: LPL100601, A Clinical Outcomes Study of Darapladib versus Placebo in Subjects with Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00799903 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: darapladib Trade Name: darapladib Study Indication: Atherosclerosis Study part: Lifestyle Questionnaire.

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial